|
 |
|
| |
|
Newsletter Sponsor
|
|
Efficiently Derisk Your Products With Adare
A clear standard for identifying APIs susceptible to NDSRI formation has remained elusive – until now. Adare’s team of nitrosamine experts have developed a straightforward framework that simplifies the identification of at-risk APIs. In our newest article, we outline three simple and straightforward questions you can use to determine if an API is susceptible to nitrosiation.
 |
 |
|
|
|
|
|
|
|
|
 |
Featured Video |
 |
|
| |
|
|
|
A Solid Dosage Future
In the pharmaceutical manufacturing space, while biopharmaceuticals often dominate discussions, it's crucial to acknowledge the enduring significance of solid dosage products (e.g., tablets, capsules,...
read more » |
 |
|
|
|
| |
|
|
|
|
|
|
|
|
Events
|
|
|
| |
|
|
|
AAPS 2024 PharmSci 360
Salt Lake City, UT – 10/20/2024
AAPS PharmSci 360 delivers research from across the pharmaceutical continuum. Thousands of scientists from across the globe converge to discuss ...
event details » |
 |
|
|
|
|
|
CPHI Worldwide 2024
Fiera Milano, Italy – 10/08/2024
With 62,000 attendees, CPHI Milan is the largest gathering in the pharma industry. We help you to discover, plan and connect with the community to ...
event details » |
 |
|
|
 |
|
|